Moderna
EU drug watchdog won’t set minimum efficacy levels for potential COVID-19 vaccines
Europe's drug regulator will not set a minimum level of efficacy for potential COVID-19 vaccines when considering them for approval, it said…
Moderna on track to report late-stage COVID-19 vaccine data next month
Moderna Inc said it is on track to report early data from a late-stage trial of its experimental COVID-19 vaccine next month,…
UK starts real-time review of Moderna’s COVID-19 vaccine candidate
Moderna Inc said the United Kingdom's health regulator has started a real-time review of its experimental COVID-19 vaccine. The company has begun…
Spain’s Rovi plans to start manufacturing Moderna vaccine ‘very soon’
Spain's pharmaceutical firm Rovi , in charge of the "fill and finish" final stage of manufacturing for Moderna's COVID-19 vaccine candidate outside…
Moderna says COVID-19 vaccine unlikely to be ready before November
Moderna Inc will not be ready to apply for emergency authorization for its potential COVID-19 vaccine before the U.S. presidential election in…
Study shows Moderna COVID-19 vaccine appears safe, shows signs of working in older adults
Results from an early safety study of Moderna Inc's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at…
Moderna sees 20 million doses of COVID-19 vaccine candidate by year end
Moderna Inc announced it was on track to produce 20 million doses of its experimental coronavirus vaccine by the end of the…
Moderna says more than 40% of participants enrolled for COVID-19 vaccine trial
Drug developer Moderna Inc said it has so far enrolled 13,194 participants in the ongoing late-stage 30,000-volunteer U.S. trial testing its COVID-19…
U.S. signs $1.5 billion deal with Moderna for 100 million doses of COVID-19 vaccine
The United States has entered an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential COVID-19 vaccine for…
Swiss government signs agreement with Moderna for COVID-19 vaccine
Switzerland has signed an agreement with Moderna to secure early access to the COVID-19 vaccine the U.S. biotech company is developing, the…
Moderna prices COVID-19 vaccine at $32-$37 per dose for smaller volume deals
Moderna Inc announced smaller volume agreements for its experimental coronavirus vaccine have been priced in the range of $32 to $37 per…
Chinese-backed hackers targeted COVID-19 vaccine firm Moderna
Chinese government-linked hackers targeted biotech company Moderna Inc, a leading U.S.-based coronavirus vaccine research developer, earlier this year in a bid to…